Low-dose diclofenac potassium in U.K.
This article was originally published in The Tan Sheet
The Medicines and Healthcare Products Regulatory Agency moves a low dosage of diclofenac potassium, a non-steroidal anti-inflammatory drug, from prescription-only status to pharmacy class. Diclofenac potassium 12.5 mg tablets may be supplied without a prescription - similar to what is called "behind the counter" in the U.S. - to adults and children ages 14 and up to provide short-term relief from headaches, symptoms associated with flu or cold and mild to moderate pain relief, according to a July 8 update by MHRA. Diclofenac potassium is available in the U.S. only in 50 mg prescription products, according to FDA records...
You may also be interested in...
Despite AI and digital analytics playing an increasing role in pharma, the industry lags others globally, a recent event heard. Meanwhile, top Indian players including Sun Pharma, Cipla and others shared what is driving their initiatives, ranging from a 'touchless factory' to virtual training and lessons learned along the way.
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.
Broader than initially reported, Merck & Co.’s agreement with BARDA extends beyond J&J’s recently authorized vaccine to other COVID-19 vaccines and therapeutics as needed.